4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-020613
Chief Commercial Officer gave up 34,165 shares (to pay taxes)
- Chief Commercial Officer acquired 120,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kirby Daniel Gordon · Chief Commercial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-24 | Exercise or conversion : show line 1 in the form | +120,000 | 173,546 | D | ||
| 2026-02-24 | Shares withheld for taxes : show line 2 in the form | −34,165 | $3.78 | $129,144 | 139,381 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-24 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −150,000 | 0 | D |
Loading xslF345X05/tm267318-1_4seq1.xml…